Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Therapeutics II - Exam 6/Final > PAH > Flashcards

PAH Flashcards

moreland-head (102 cards)

Start Studying
1
Q

blood flow of oxygen-poor blood through the heart

A

superior/inferior vena cava –> right atrium –> tricuspid valve –> right ventricle –> pulmonary valve –> pulmonary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

blood flow of oxygen-rich blood through the heart

A

pulmonary veins –> left atrium –> mitral valve –> left ventricle –> aorticle valve –> aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathophysi of PAH

A

pulmonary arterioles narrow –> RV dilates –> pulmonary edema and damage –> thrombi and/or plexiform lesion formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pulmonary HTN (PH)

A

higher than normal BP in the arteries that carry blood away from the heart into the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

levels of PH

A

mean pulmonary artery pressure (MPAP) equal to or greater than 20 mmHg at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is PAH?

A

pulmonary arterial HTN
progressive disease involving endothelial dysfunction
characterized by elevated pulmonary arterial pressure and pulmonary vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the classifications of WHO PH?

A

1 – PAH
2 – left heart disease
3 – lung disease
4 – chronic thromboembolic PH
5 – PH resulting from unclear mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the causes of PAH?

A

idiopathic/unknown
genetic
drug and toxin exposure
CHD
HIV
connective tissue disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the causes of PH secondary to left heart disease?

A

CAD
HTN
heart valve disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the causes of PH secondary to lung disease?

A

COPD
interstitial lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the causes of chronic thromboembolic PH?

A

old, disorganized blood clots in the lungs create a physical barrier to blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how should chronic thromboembolic PH be treated?

A

surgical removal of clot
medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the causes of PH resulting from unclear mechanisms?

A

sarcoidosis, blood diseases (anemia), history of spleen remove, metabolic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the incidence of PH by WHO classification?

A

unknown causes > lung disease > left heart disease and PAH > chronic thromboembolic PH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the risk factors of PAH?

A

older age
female
poor exercise capacity
high right atrial pressure
right ventricular dysfunction
low CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is need in the diagnosis of PAH?

A

right heart catheterization
echocardiogram
exercise testing
biomarkers (BNP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are some early signs and symptoms of PAH?

A

dizziness
SOB
palpitations
fatigue
edema (non-specific)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the late signs and symptoms of PAH?

A

syncope
jugular venous distension
SOB
chest pain
hepatomegaly
swollen abdomen
low BP (signs of right-sided HF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what levels are indicative of PAH?

A

over 20 mmHg mPAP
under 15 PAWP
over 2 wood units PVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is PAWP?

A

pulmonary arterial wedge pressure
reflects left atrial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is normal PAWP?

A

4-12 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the indicators of elevated PAWP?

A

left ventricular failure or mitral stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is PVR?

A

pulmonary vascular resistance
calculated by mPAP and PAWP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is WHO-FC 1?

A

no limitation of physical activity
ordinary physical activity does not cause undue dyspnea, fatigue, chest pain, or near syncope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
what is WHO-FC II?
slight limitation of physical activity comfortable at rest, but ordinary physical activity causes undue dyspnea, fatigue, chest pain , or near syncope
26
what is WHO-FC III?
marked limitation of physical activity comfortable at rest but less than ordinary physical activity causes undue dyspnea, fatigue, chest pain, or near syncope
27
what is WHO-FC IV?
inability to carry out physical activity without symptoms (increased discomfort) signs of right HF dyspnea or fatigue at rest
28
what drugs are available to treat PAH?
CCB PDE-5i sGC stimulator ERAs prostacyclins direct pulmonary vasodilator (NO, inpatient only)
29
what is the recommended treatment of PAH with cardiopulmonary comorbidity?
oral monotherapy with PDE5i or ERA
30
what is the treatment of PAH in class II or III, low-intermediate risk patients?
1. ERA + PDE-5i therapy 2. evaluate risk at follow up
31
at treatment follow up, how should an intermediate risk of PAH be treated?
add PRA or switch from PDE-5i to sGC
32
at treatment follow up, how should an intermediate-high or high risk of PAH be treated?
add IV or SQ prostacyclins evaluate lung transplantation
33
how should PAH in class II or III, high risk be treated?
1. ERA + PDE5-i therapy + IV/SQ prostacyclins 2. evaluate risk
34
what test should be conducted following PAH diagnosis?
vasoreactivity rest in cath lab to predict the response to CCBs
35
what does a positivity vasoreactivity test mean?
drop in mPAP over 10 mmHg with PAP under 40 mmHg and stable-improved cardiac output CCBs can be used (but guaranteed to have a response)
36
when should CCB therapy be assessed in PAH?
3-6 months after initiation then every 6-12 months after
37
what CCBs should be used to treat PAH?
long acting nifedipine long acting diltiazem, amlodipine
38
why can verapamil not be used in PAH?
has negative inotropic effects
39
what drugs used to treat PAH act in the nitric oxide pathway?
PDE5-i sGC stimulators
40
how does the nitric oxide pathway influence the body?
vasodilation antiproliferation
41
what is the MOA of PDE-5i
increase the levels of cGMP to promote muscle relaxation and vasodilation reduce conversion of cGMP to GMP
42
what drugs are PDE-5i?
sildenafil tadalafil
43
what are the benefits of PDE-5i in PAH treatment?
improved 6MWD and functional capacity
44
what is 6mwd?
6 minute walk distance
45
what drugs should be avoided when taking a PDE5i?
riociguat and nitrates due to increase risk of hypotension CYP3A4 substrates
46
what are the SE of PDE5i?
flushing HA dyspepsia visual disturbances (blue-tinged vision) priapism tinnitus/hearing loss sudden vision loss hypotension
47
what is riociguat?
adempas soluble guanylate cyclase stimulator (sGCs) used as an alternative to PDE5i in PAH therapy
48
what are the benefits of riociguat in PAH treatment?
improves exercise capacity, WHO FC, and time to clinical worsening has anti proliferative and anti-remodeling activity
49
what drugs are ERAs?
bosentan ambrisentan macitentan
50
what is bosentan?
mixed ETa ETb ERA
51
what is ambrisentan?
ETa selective ERA
52
what is macitentan?
mixed ETb and ETa ERA
53
what is the location and function of ETa receptors?
located on pulmonary smooth muscle walls function in vasoconstriction, proliferation, and inflammation
54
what is the location and function of ETb receptors?
located on endothelium and muscle cells of vascular walls on endothelium, function in vasodilation, stimulate NO and prostacyclin production on muscle cells, function in vasoconstriction and cell proliferation
55
how do ETb receptors express in PAH?
up regulated in the media of blood vessels, causing vasoconstriction
56
what are the benefits associated with ERAs?
improved exercise capacity, functional capacity, hemodynamic parameters, time to clinical worsening, and WHO FC
57
how long does it take to see improvement while on ERA?
8-10 weeks
58
what is the MOA of ERAs?
block endothelin receptors on VSM to reduce vasoconstriction and cell proliferation
59
what is the AE of ERAs?
peripheral edema (A>B>M), LFT abnormalities (B>M>A), anemia
60
what are SE specific to ambrisentan?
HA nasal congestion
61
what are the black box warnings of ERAs?
embryo-fetal toxicity (avoid in pregnancy) hepatotoxicity (bosentan only)
62
what are the CI of ERAs?
hepatic impairment -- dont start if LFT over 3x ULN
63
what should be monitored in ERAs?
pregnancy status LFTs hemoglobin
64
what are the effects of prostacyclin activation?
vasodilation and antiproliferation (stimulate cAMP)
65
what drug classes are involved in the prostacyclin pathway?
prostacyclins prostacyclin IP receptor agonists
66
what agents are prostacyclins?
epoprostenol treprostinil
67
what dosage form does epoprostenol come in?
IV
68
what dosage form does treprostinil come in?
IV SQ (prefered) inhaled PO
69
what drug is a prostacyclin IP receptor agonist?
selexipag
69
what dosage form is selexipag?
PO
70
what are the indications of parenteral prostacyclins?
first line treatment of class IV PAH first line treatment of rapidly progressing class III PAH standard treatment of severe PH with RV failure
71
what are the benefits of prostacyclins?
improve symptoms, 6MWD, hemodynamics, and mortality (epoprostenol only)
72
what is the MOA of prostacyclins?
induce vasodilation in all vascular beds and inhibit platelet aggregation has cytoprotective and anti proliferative effects
73
what are the common SE of prostacyclins?
HA jaw and limb pain flushing/skin rash NVD thrombocytopenia (more i epoprostenol) hypotension
74
what are the SE of oral prostacyclins?
diarrhea anemia
75
what are the SE of inhaled prostacyclins?
cough throat irritation
76
what are the SE of IV prostacyclins?
line infections erythema
77
what are the SE of SQ prostacyclins?
site pain infusion site reactions
78
what happens if you missed a dose of oral treprostinil?
if over 2 doses are missed, you must re-titrate dosed BID or q8h
79
what happens if therapy is interrupted in selexipag?
if over 3 days, titrate is required again do not crush or chew tablets
80
what are the CI of selexipag?
strong CYP2C8 inhibitors (gemfibrozil)
81
what is unique about inhaled treprostinil?
1 ampule is 24 hour of therapy with 2-3 minute treatments a DPI is a new cartridge with each session so no charging
82
what is the dosing of treprostinil?
start in hospital at 1-3 ng/kg/min titrate q8-12h up to 10-20 ng/kg/min then weekly at home by 2 ng/kg/min increments up to goal dose of 50-80 ng/kg/min
83
why is SQ preferred in treprostinil?
avoids risk of central lines compared to IV
84
what is flolan?
non-thermostable product of epoprostenol whose back-up cassettes must be kept on ice
85
what is veletri?
thermostable product of epoprostenol that is stable for 48 hours
86
when should epoprostenol be co-administered?
never with any other fluids due to increase in CV collapse and death risk incompatible with everything
87
what is the result of abrupt d/c of epoprostenol?
accelerated PH crisis
88
what are the CP of epoprostenol?
always needs back-up cassette prepared
89
what are common medication errors of prostacyclins?
flushing of line calculation or concentration error programming error pump turned off inappropriate change in weight
90
what are the most common SE of combo therapy between ERA and PDE5-i?
nasal congestion peripheral edema headache dizziness anemia
91
is triple or dual therapy more effective in newly diagnosed PAH patients?
dual
92
what cardiopulmonary comorbidities?
any condition that may worsen left ventricular function or lung function (to then worsen RV function and PH)
93
what are cardiovascular comorbidities?
obesity HTN diabetes coronary artery disease
94
what is a pulmonary comorbidity?
interstitial lung disease (fibrotic lungs)
95
what is sotatercept?
activin signaling inhibitor
96
when are diuretics used in PAH?
may be used with right HF symptoms monitor kidney function and weight
97
when are CV drugs used in PAH?
to treat underlying (left-sided) heart disease that requires their use
98
what PAH agents are safe to use in pregnancy?
CCBs PDE5i prostacyclins
99
what PAH agents are to be avoided in pregnancy?
ERAs riociguat selexipag
100
how is O2 used in PAH?
use supplemental O2 if needed at sea level or an extended time at altitudes > 1500 m
101
when should lung transplantation?
consider in FC III or IV patients with inadequate response to maximal pharmacotherapy

Therapeutics II - Exam 6/Final (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions